Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.2B | $2.9B | $2.8B |
| YoY growth | +12.2% | +7.2% | -2.4% | -6.4% | -9.3% |
| Gross margin | 56.2% | 54.2% | 56.3% | 53.4% | 55.0% |
| Operating margin | 47.3% | 22.3% | 28.1% | 23.5% | 25.5% |
| Net income | $1.1B | $468M | $646M | $457M | $497M |
| Diluted EPS | 4.43 | 1.80 | 2.48 | 1.75 | 1.92 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
More optimistic than in the previous 10-Q (2026-04-28: +11, +7 points)
10-Q of 2026-07-28 · 35.0% positive sentences, 15.3% negative · 177 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier |
0.4% | $94.8M | +28% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for NXPI →
| 2026-10-01 | Jensen Christopher L · Officer | Sell (10b5-1 plan) | $805K | SEC ↗ |
| 2026-09-15 | Micallef Andrew · Officer | Sell (10b5-1 plan) | $226K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.